Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 191 | 183 | 176 | 163 | 322 |
| Operating Income | -191 | -183 | -176 | -163 | -322 |
| Other Income | 172 | 258 | 392 | 383 | 320 |
| Pre-tax Income | -19 | 75 | 217 | 220 | -3 |
| Income Tax | -4 | 16 | 41 | 32 | -32 |
| Net Income Continuous | -15 | 59 | 176 | 188 | 29 |
| Net Income | $-15 | $59 | $176 | $188 | $29 |
| EPS Basic Total Ops | -0.10 | -0.40 | -0.30 | -0.30 | -1.00 |
| EPS Basic Continuous Ops | -0.06 | 0.21 | 0.63 | 0.69 | 0.11 |
| EPS Diluted Total Ops | -0.10 | -0.40 | -0.30 | -0.30 | -1.00 |
| EPS Diluted Continuous Ops | -0.06 | 0.21 | 0.63 | 0.69 | 0.11 |
| EBITDA(a) | $-191 | $-183 | $-176 | $-163 | $-322 |